An eight-long non-coding RNA signature as a candidate prognostic biomarker for lung cancer

Oncology Reports

Volumn 36, Issue 1, 2016, Pages 215-222

  Tu, Zhenbo ^a   He, Du ^b   Deng, Xinzhou ^a   Xiong, Meng ^a   Huang, Xiaoxing ^a   Li, Xinran ^a   Hao, Ling ^a   Ding, Qianshan ^c   Zhang, Qiuping ^a  

^a WUHAN UNIVERSITY   (China)

^b Enshi Tujia and Miao Autonomous Prefecture   (China)

^c RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Gene signature; Long non coding RNA; Lung cancer; Survival

Indexed keywords

LONG UNTRANSLATED RNA; TUMOR MARKER;

AF085995 GENE; AK000053 GENE; AK021595 GENE; AK022024 GENE; AK124307 GENE; ALGORITHM; ARTICLE; BC020384 GENE; BC030759 GENE; BIOINFORMATICS; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; CR615992 GENE; DNA REPLICATION; GENE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC DATABASE; HIGH RISK POPULATION; HUMAN; LOW RISK POPULATION; LUNG CANCER; MAJOR CLINICAL STUDY; NONBIOLOGICAL MODEL; PATIENT CODING; PRIORITY JOURNAL; RANDOM SURVIVAL FOREST ALGORITHM; RISK SCORE MODEL; SURVIVAL RATE; SURVIVAL TIME; VALIDATION PROCESS; CELL CYCLE; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; PATHOLOGY; PROCEDURES; PROGNOSIS; SIGNAL TRANSDUCTION;

BIOMARKERS, TUMOR; CELL CYCLE; DNA REPLICATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; PROGNOSIS; RNA, LONG NONCODING; SIGNAL TRANSDUCTION;

EID: 84971440554     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2016.4817     Document Type: Article

References (49)

1. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
2. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin 65: 87-108, 2015.
3. DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, Alteri R, Robbins AS and Jemal A: Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 64: 252-271, 2014.
4. Ling H, Vincent K, Pichler M, Fodde R, Berindan-Neagoe I, Slack FJ and Calin GA: Junk DNA and the long non-coding RNA twist in cancer genetics. Oncogene 34: 5003-5011, 2015.
5. Lipovich L, Johnson R and Lin CY: MacroRNA underdogs in a microRNA world: Evolutionary, regulatory, and biomedical significance of mammalian long non-protein-coding RNA. Biochim Biophys Acta 1799: 597-615, 2010.
6. Fatica A and Bozzoni I: Long non-coding RNAs: New players in cell differentiation and development. Nat Rev Genet 15: 7-21, 2014.
7. Qi P and Du X: The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod Pathol 26: 155-165, 2013.
8. Yarmishyn AA, Batagov AO, Tan JZ, Sundaram GM, Sampath P, Kuznetsov VA and Kurochkin IV: HOXD-AS1 is a novel lncRNA encoded in HOXD cluster and a marker of neuroblastoma progression revealed via integrative analysis of noncoding transcriptome. BMC Genomics 15 (Suppl 9): S7, 2014.
9. Crea F, Watahiki A, Quagliata L, Xue H, Pikor L, Parolia A, Wang Y, Lin D, Lam WL, Farrar WL, et al: Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer. Oncotarget 5: 764-774, 2014.
10. Shen X, Xie B, Ma Z, Yu W, Wang W, Xu D, Yan X, Chen B, Yu L, Li J, et al: Identification of novel long non-coding RNAs in triple-negative breast cancer. Oncotarget 6: 21730-21739, 2015.
11. Sun J, Chen X, Wang Z, Guo M, Shi H, Wang X, Cheng L and Zhou M: A potential prognostic long non-coding RNA signature to predict metastasis-free survival of breast cancer patients. Sci Rep 5: 16553, 2015.
12. Meng J, Li P, Zhang Q, Yang Z and Fu S: A four-long non-coding RNA signature in predicting breast cancer survival. J Exp Clin Cancer Res 33: 84, 2014.
13. Zhou M, Wang X, Shi H, Cheng L, Wang Z, Zhao H, Yang L and Sun J: Characterization of long non-coding RNA-associated ceRNA network to reveal potential prognostic lncRNA biomarkers in human ovarian cancer. Oncotarget: Feb 3, 2016 (Epub ahead of print). doi: 10.18632/oncotarget.7181.
14. Malek E, Jagannathan S and Driscoll JJ: Correlation of long non-coding RNA expression with metastasis, drug resistance and clinical outcome in cancer. Oncotarget 5: 8027-8038, 2014.
15. Chen F, Tian Y, Pang EJ, Wang Y and Li L: MALAT2-activated long noncoding RNA indicates a biomarker of poor prognosis in gastric cancer. Cancer Gene Ther: Feb 27, 2015 (Epub ahead of print). doi: 10.1038/cgt.2015.6.
16. Xue Y, Ma G, Gu D, Zhu L, Hua Q, Du M, Chu H, Tong N, Chen J, Zhang Z, et al: Genome-wide analysis of long noncoding RNA signature in human colorectal cancer. Gene 556: 227-234, 2015.
17. Hu Y, Chen HY, Yu CY, Xu J, Wang JL, Qian J, Zhang X and Fang JY: A long non-coding RNA signature to improve prognosis prediction of colorectal cancer. Oncotarget 5: 2230-2242, 2014.
18. Zhou M, Zhao H, Wang Z, et al: Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma. J Exp Clin Cancer Res 34: 102, 2015.
19. Rousseaux S, Debernardi A, Jacquiau B, Vitte AL, Vesin A, Nagy-Mignotte H, Moro-Sibilot D, Brichon PY, Lantuejoul S, Hainaut P, et al: Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers. Sci Transl Med 5: 186ra66, 2013.
20. Yamauchi M, Yamaguchi R, Nakata A, Kohno T, Nagasaki M, Shimamura T, Imoto S, Saito A, Ueno K, Hatanaka Y, et al: Epidermal growth factor receptor tyrosine kinase defines critical prognostic genes of stage I lung adenocarcinoma. PLoS One 7: e43923, 2012.
21. Botling J, Edlund K, Lohr M, Hellwig B, Holmberg L, Lambe M, Berglund A, Ekman S, Bergqvist M, Pontén F, et al: Biomarker discovery in non-small cell lung cancer: Integrating gene expression profiling, meta-analysis, and tissue microarray validation. Clin Cancer Res 19: 194-204, 2013.
22. Hou J, Aerts J, den Hamer B, van Ijcken W, den Bakker M, Riegman P, van der Leest C, van der Spek P, Foekens JA, Hoogsteden HC, et al: Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PLoS One 5: e10312, 2010.
23. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B and Speed TP: Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31: e15, 2003.
24. Risueño A, Fontanillo C, Dinger ME and De Las Rivas J: GATExplorer: Genomic and transcriptomic explorer; mapping expression probes to gene loci, transcripts, exons and ncRNAs. BMC Bioinformatics 11: 221, 2010.
25. Pang KC, Stephen S, Engström PG, Tajul-Arifin K, Chen W, Wahlestedt C, Lenhard B, Hayashizaki Y and Mattick JS: RNAdb - a comprehensive mammalian noncoding RNA database. Nucleic Acids Res 33: D125-D130, 2005.
26. Sun L, Luo H, Bu D, Zhao G, Yu K, Zhang C, Liu Y, Chen R and Zhao Y: Utilizing sequence intrinsic composition to classify protein-coding and long non-coding transcripts. Nucleic Acids Res 41: e166, 2013.
27. Simon R, Lam A, Li MC, Ngan M, Menenzes S and Zhao Y: Analysis of gene expression data using BRB-ArrayTools. Cancer Inform 3: 11-17, 2007.
28. Ishwaran H and Kogalur UB: Consistency of random survival forests. Stat Probab Lett 80: 1056-1064, 2010.
29. Bralten LB and French PJ: Genetic alterations in glioma. Cancers 3: 1129-1140, 2011.
30. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102: 15545-15550, 2005.
31. Merico D, Isserlin R, Stueker O, Emili A and Bader GD: Enrichment map: A network-based method for gene-set enrichment visualization and interpretation. PLoS One 5: e13984, 2010.
32. Huang W, Sherman BT and Lempicki RA: Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1-13, 2009.
33. Dinger ME, Pang KC, Mercer TR, Crowe ML, Grimmond SM and Mattick JS: NRED: A database of long noncoding RNA expression. Nucleic Acids Res 37: D122-D126, 2009.
34. Du Z, Fei T, Verhaak RG, Su Z, Zhang Y, Brown M, Chen Y and Liu XS: Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer. Nat Struct Mol Biol 20: 908-913, 2013.
35. Williams GH and Stoeber K: The cell cycle and cancer. J Pathol 226: 352-364, 2012.
36. Kim T, Jeon YJ, Cui R, Lee JH, Peng Y, Kim SH, Tili E, Alder H and Croce CM: Role of MYC-regulated long noncoding RNAs in cell cycle regulation and tumorigenesis. J Natl Cancer Inst 107: pii: dju505, 2015.
37. Macheret M and Halazonetis TD: DNA replication stress as a hallmark of cancer. Annu Rev Pathol 10: 425-448, 2015.
38. Yang G, Lu X and Yuan L: LncRNA: A link between RNA and cancer. Biochim Biophys Acta 1839: 1097-1109, 2014.
39. Li J, Chen Z, Tian L, Zhou C, He MY, Gao Y, Wang S, Zhou F, Shi S, Feng X, et al: LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma. Gut 63: 1700-1710, 2014.
40. Fernando TR, Rodriguez-Malave NI, Waters EV, Yan W, Casero D, Basso G, Pigazzi M and Rao DS: LncRNA expression discriminates karyotype and predicts survival in B-lymphoblastic leukemia. Mol Cancer Res 13: 839-851, 2015.
41. Yang YR, Zang SZ, Zhong CL, Li YX, Zhao SS and Feng XJ: Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer. Int J Clin Exp Pathol 7: 6929-6935, 2014.
42. Xie X, Liu HT, Mei J, Ding FB, Xiao HB, Hu FQ, Hu R and Wang MS: LncRNA HMlincRNA717 is down-regulated in non-small cell lung cancer and associated with poor prognosis. Int J Clin Exp Pathol 7: 8881-8886, 2014.
43. Han L, Zhang EB, Yin DD, Kong R, Xu TP, Chen WM, Xia R, Shu YQ and De W: Low expression of long noncoding RNA PANDAR predicts a poor prognosis of non-small cell lung cancer and affects cell apoptosis by regulating Bcl-2. Cell Death Dis 6: e1665, 2015.
44. Lin L, Gu ZT, Chen WH and Cao KJ: Increased expression of the long non-coding RNA ANRIL promotes lung cancer cell metastasis and correlates with poor prognosis. Diagn Pathol 10: 14, 2015.
45. Zhang X, Sun S, Pu JK, Tsang AC, Lee D, Man VO, Lui WM, Wong ST and Leung GK: Long non-coding RNA expression profiles predict clinical phenotypes in glioma. Neurobiol Dis 48: 1-8, 2012.
46. Zhou M, Guo M, He D, Wang X, Cui Y, Yang H, Hao D and Sun J: A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer. J Transl Med 13: 231, 2015.
47. Desjobert C, El Maï M, Gérard-Hirne T, Guianvarc'h D, Carrier A, Pottier C, Arimondo PB and Riond J: Combined analysis of DNA methylation and cell cycle in cancer cells. Epigenetics 10: 82-91, 2015.
48. Tachibana KE, Gonzalez MA and Coleman N: Cell-cycle-dependent regulation of DNA replication and its relevance to cancer pathology. J Pathol 205: 123-129, 2005.
49. Falaschi A, Abdurashidova G and Biamonti G: DNA replication, development and cancer: A homeotic connection? Crit Rev Biochem Mol Biol 45: 14-22, 2010.